UBS analyst Dan Leonard raised the firm’s price target on Iqvia (IQV) to $280 from $250 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- Iqvia price target raised to $290 from $265 at Truist
- IQVIA Holdings: Positioned for Growth with Strategic Innovations and Industry Recovery
- Iqvia price target raised to $273 from $254 at Stifel
- Iqvia price target raised to $260 from $245 at BofA
- Iqvia price target raised to $230 from $200 at Barclays